In experimental models, VEGF-TKIs correlate with a decrease in renin activity, but angiotensin-converting enzyme (ACE) inhibitors have a limited impact on hypertension compared with Ca2+-channel blockers [6]. The gene discussed is ACE; the disease is hypertensive disorder.